Martin Shkreli (C), former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals, departs following a hearing at a U.S. federal court in New York City on June 6, 2016.

Martin Shkreli has some questions about... Martin Shkreli.

Prospective jurors at the upcoming trial of accused securities fraudster Shkreli will have to answer a special questionnaire about the notorious pharma bro if his criminal defense attorneys get their wish.